TABLE 2.
Coverage with hepatitis B vaccines among children 5–10 years in selected municipalities at high-risk for HBV transmission—Colombia, 2019
| Vaccination card (n = 1741) | Verbal report (n = 1462) | Either source (n = 3203) | ||||
|---|---|---|---|---|---|---|
| Vaccine | N | % (Wilson 95% CI) | N | % (Wilson 95% CI) | N | % (Wilson 95% CI) |
| Hepatitis B Birth Dose | ||||||
| Any | 1663 | 50.3 (47.4–53.3) | 1371 | 45.3 (42.4–48.3) | 3034 | 95.6 (94.7–96.4) |
| Timelya | 1099 | 32.2 (29.9–34.6) | 1157 | 38.9 (36.0–41.9) | 2256 | 71.1 (68.5–73.6) |
| Pentavalent vaccineb | ||||||
| Any | 1713 | 51.8 (48.8–54.7) | 1389 | 45.7 (42.9–48.6) | 3102 | 97.5 (96.7–98.1) |
| 3 doses (HepB3) | 1687 | 51.0 (48.1–53.9) | 1348 | 44.4 (41.6–47.2) | 3035 | 95.4 (94.3–96.3) |
a
Defined as Days 0 or 1 for card confirmed, ≤24 h of birth for oral report.
b
Includes hepatitis B, diphtheria, pertussis, tetanus and H. influenzae type B.